氧化物对氧化信号的调节:对神经退行症的影响
Veerta Sharma1, Prateek Sharma1, Thakur Gurjeet Singh2
1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Molecular biology reports
|September 11, 2025
概括
神经退行性疾病正在上升. 黄酸盐,天然化合物,可以通过抑制氧化 (NO) 的过度生产来帮助治疗这些疾病,氧化是疾病进展的关键因素.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 神经退行性疾病 (NDD) 是一个日益严重的全球健康挑战.
- 氧化 (NO) 是一种与炎症有关的神经递质;其失调有助于NDD.
- 目前的NDD治疗效果有限,副作用很大.
研究的目的:
- 审查氧化 (NO) 在神经退行性疾病 (NDD) 病原发生中的作用.
- 探索天然黄素在NDD治疗中调节NO通路方面的潜力.
- 讨论黄类药物可以抑制NDD中NO生产的分子机制.
主要方法:
- 关于氧化 (NO) 生产及其在神经退行性疾病 (NDD) 中的作用的文献综述.
- 对天然黄类药物药理性质的研究分析,包括抗氧化,抗炎和抗丧作用.
- 检查涉及NO生产和黄胺介导抑制的分子途径.
主要成果:
- 过度的氧化 (NO) 生产会加剧氧化应激和炎症,导致神经退行.
- 黄素具有抗氧化和抗炎性质,可以抵消NO诱导的细胞损伤.
- 黄类药物调节分子通路以抑制过度的NO生成,提供一种潜在的治疗策略.
结论:
- 减少氧化 (NO) 的过度生产是神经退行性疾病 (NDD) 的一个有希望的治疗目标.
- 天然黄类药物通过抑制NO通路来证明其作为安全有效的NDD管理剂的潜力.
- 饮食干预和黄类补充剂需要进一步研究神经保护.
更多相关视频
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
13.3K
08:58En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
10.0K
相关概念视频
01:28Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K
01:26Coronary Artery Disease II: Pathophysiology
376
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376
01:16Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
563
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
563
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190